scorecard

You Searched For "vaccine makers" and got 20 results


Sort By:


Business Insider Latest Story Image
3 mins read

The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires

India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…

Business Insider Latest Story Image
1 min read

Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business

Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…

Zinya Salfiti   


Business Insider Latest Story Image
3 mins read

Vaccine makers are making over $1,000 per second and furiously holding on to their monopolies

The COVID-19 pandemic created over 40 new billionaires in the pharmaceutical sector in the last two…

Business Insider Latest Story Image
1 min read

Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial

The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …

Phil Rosen   


Business Insider Latest Story Image
3 mins read

Huileng Tan   


Business Insider Latest Story Image
1 min read

Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report

Both SII and Bharat Biotech are involved in producing Covid-19 vaccine. Moreover, Cyfirma add…

Business Insider Latest Story Image
1 min read

Moderna tanks 14% after COVID-19 vaccine maker cuts yearly sales outlook and misses 3rd-quarter expectations

Short-term supply constraints led Moderna to cut its 2022 revenue outlook to a range of $18 billion…

Carla Mozée   


Business Insider Latest Story Image
1 min read

Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows

Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…

Carla Mozée   


Business Insider Latest Story Image
2 mins read

Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it

The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

How vaccine-makers are combating variants

These are Business Insider's biggest healthcare stories for February 1.

Lydia Ramsey Pflanzer   


Business Insider Latest Story Image
2 mins read

Carla Mozée   


Business Insider Latest Story Image
2 mins read

India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did

Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…

Business Insider Latest Story Image
2 mins read

Marjorie Taylor Greene, who has boasted about being unvaccinated, owns stock in 3 major vaccine makers

Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & John…

Bill Bostock   


Business Insider Latest Story Image
2 mins read

Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses

stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…

PTI   


Business Insider Latest Story Image
2 mins read

Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world

"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…

Matthew Fox   


Business Insider Latest Story Image
3 mins read

Bharat Biotech to make antigen for first-ever anti-malaria vaccine

The first dose of the vaccine has reached more than 500,000 children since the pilots we…

Business Insider Latest Story Image
1 min read

Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue

The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…

Matthew Fox   


Business Insider Latest Story Image
4 mins read

A woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yet

Pfizer's Lyme vaccine trial, if successful, could herald the first major advance in the fight again…

Hilary Brueck   


Business Insider Latest Story Image
1 min read

Moderna slumps 11% as the vaccine-maker's Q1 revenue misses estimates

The pharma company's full-year sales forecast for its vaccine was raised to $19.2 billion, up from …

Shalini Nagarajan